Senores Pharma.

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
778.00
-6.25 (-0.8%)
BSENSE

Dec 05

BSE+NSE Vol: 1.7 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Operating Income
398.00
214.00
35.00
14.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
398.00
214.00
35.00
14.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
0.00
-2.00
Raw Materials Consumed
181.00
102.00
13.00
10.00
Power & Fuel Cost
9.00
2.00
0.00
0.00
Employee Cost
60.00
35.00
4.00
2.00
Operating Expenses
24.00
11.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
3.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
308.00
172.00
22.00
12.00
Operating Profit (PBDIT) excl Other Income
89.00
41.00
12.00
1.00
Other Income
19.00
2.00
3.00
0.00
Operating Profit (PBDIT)
108.00
44.00
16.00
2.00
Interest
21.00
9.00
2.00
0.00
Profit before Depriciation and Tax
87.00
34.00
14.00
1.00
Depreciation
16.00
10.00
1.00
0.00
Profit Before Taxation & Exceptional Items
70.00
24.00
12.00
1.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
70.00
24.00
12.00
1.00
Provision for Tax
12.00
-7.00
4.00
0.00
Profit After Tax
58.00
32.00
8.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
41.00
10.00
1.00
0.00
Profit Available for appropriations
100.00
41.00
10.00
1.00
Appropriations
100.00
41.00
10.00
1.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
16.12
13.67
8.87
1.81
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 85.65% vs 507.07% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 115.68% vs 228.26% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 128.04% vs 342.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 78.36% vs 287.88% in Mar 2024

Compare Profit and Loss Results of Senores Pharma.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
398.00
130.00
268.00
206.15%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
9.00
-9.00
-100.00%
Net Sales
398.00
120.00
278.00
231.67%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
-3.00
-100.00%
Raw Materials Consumed
181.00
38.00
143.00
376.32%
Power & Fuel Cost
9.00
3.00
6.00
200.00%
Employee Cost
60.00
20.00
40.00
200.00%
Operating Expenses
24.00
7.00
17.00
242.86%
General and Administration Expenses
-1.00
13.00
-14.00
-107.69%
Selling and Distribution Expenses
3.00
5.00
-2.00
-40.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
308.00
98.00
210.00
214.29%
Operating Profit (PBDIT) excl Other Income
89.00
22.00
67.00
304.55%
Other Income
19.00
3.00
16.00
533.33%
Operating Profit (PBDIT)
108.00
26.00
82.00
315.38%
Interest
21.00
11.00
10.00
90.91%
Profit before Depriciation and Tax
87.00
14.00
73.00
521.43%
Depreciation
16.00
4.00
12.00
300.00%
Profit Before Taxation & Exceptional Items
70.00
9.00
61.00
677.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
70.00
9.00
61.00
677.78%
Provision for Tax
12.00
1.00
11.00
1,100.00%
Profit After Tax
58.00
8.00
50.00
625.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
1.00
-1.00
-100.00%
Profit Balance B/F
41.00
-10.00
51.00
510.00%
Profit Available for appropriations
100.00
-1.00
101.00
10,100.00%
Appropriations
100.00
-1.00
101.00
10,100.00%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
16.12
5.7526
10.37
180.22%
Profit And Loss - Net Sales
Net Sales 398.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 85.65% vs 507.07% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 89.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 115.68% vs 228.26% in Mar 2024

Profit And Loss - Interest
Interest 21.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 128.04% vs 342.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 58.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 78.36% vs 287.88% in Mar 2024